Clinical Trials
2
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)
Phase 2
Active, not recruiting
- Conditions
- Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease, Early Onset
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- PRInnovation GmbH
- Target Recruit Count
- 270
- Registration Number
- NCT06182085
- Locations
- 🇨🇿
Neuro Health Centrum ltd., Brno, Czechia
🇨🇿NeuropsychiatrieHK, s.r.o., Hradec Králové, Czechia
🇨🇿A-Shine, s.r.o., Plzen, Czechia
News
No news found